Sunday, 26 January 2014

Randomly Amplified Polymorphic DNA

Randomly amplified polymorphic dna (RAPD) as the name suggests are the products of a PCR  reaction primed by arbitrarily selected primers.

How is it different from conventional PCR?

In conventional PCR, one designs the forward and reverse primers with the aim that they will anneal to the gene of interest. In order to accomplish this, it is necessary that one knows the sequence of the gene of interest. The next few steps follow a cycle wherein the primers first anneal, then a polymerase extends them and again the extended products are denatured making them ready for the next cycle of primer annealing.

In case of RAPD, the knowledge of the gene sequence is not a pre-requisite. One selects random primers which at low temperature display lower fidelity and hence anneal to many arbitrary sites on the DNA template with a variety of mismatches. After a few initial steps of annealing at lower temperature the amplification may then be carried out according to the conventional PCR or may also be continued even at the same temperature. When these amplified products are run on a gel, a pattern of bands is obtained which is unique for a particular species and is dependent upon the primers used.

Selection of primers

A single random primer will seldom be informative. When we use many such primers and then score them; will the RAPD profile make some sense in terms of polymorphism. Polymorphism maybe detected when the fingerprint of one sample shows an amplified band while the other sample does not even when the same primer is used with both the samples.

RAPD may be generated due to mutation in template (insertions/deletions) or presence of alleles in heterozygous individuals. However, these cannot be pinpointed as such because RAPD markers are dominant i.e they amplify many loci in a single go with a single primer.     

Some of the amplified bands are easily recognizable while some others may be difficult to interpret. The ambiguity arises due to the fact that every primer will possess different power to distinguish between different sites of amplification. Also there will exist competition between primers and different sites. Certain amplified fragments may interfere in the amplification or separation of other segments. Reproducibility of the RAPD pattern becomes problematic below a certain concentration of genomic DNA and may produce smears. On the other hand, there maybe poor resolution if the genomic concentration is very high                   



Reference:

Molecular Biomethods Handbook, second edition, John M Walker, Ralph Rapley,  chpt 10, pg 132-147                                                                                                                                               

What is Sitosterolemia?

Cholesterol synthesized by the human body plays an important role as part of the cell membrane. It is a type of sterol. However, plants do not synthesize cholesterol. Instead they have phytosterols of which sitosterol is a comparatively abundant phytosterol. When we eat plant derived foods, phytosterols are ingested into the body but they are not absorbed into the blood. Sitosterolemia is a rare recessive autosomal disease in which individuals absorb large quantities of plant sterols and this is stored in their blood and tissues. It is also referred to as phytosterolemia or plant sterol storage disease.

The clinical signs may include small yellowish outgrowths on various parts of the body, called xanthomas. These may also occur within the body such as in the tendons.  These are made up of accumulated lipids.  Joint stiffness and haemolytic anaemia may also be present.

The underlying cause of this genetic disorder is mutations in the genes ABCG5 or ABCG8. These genes code for a transport protein sterolin (sterolin 1 and sterolin 2 respectively) The sterolin 1 and sterolin 2 then form a heterodimer which acts as a transporter protein. Sterolin is the protein involved in transport of sterols out of the apical cells of the intestines. When there exists a mutation in any one of these genes, this transport protein malfunctions resulting in sitosterolemia. An interesting observation is that, mutations have always been seen in both the alleles of any 1 of the genes never in both of them together.


People diagnosed with sitosterolemia need to consume foods lower in plant and shellfish sterols. Patients may be given ezitimibe which acts as a sterol absorbtion inhibitor. If the individual is not responding to this therapy then use of cholestryramine and/or partial ileal bypass surgery may be recommended.



References: